¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25
±³À°ÀÏÀÚ : 2021-09-25
±³À°Àå¼Ò : ¿Â¶óÀÎ (½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀçÈ°ÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÓ»óÅëÁõÇÐȸ  
´ã´çÀÚ : ´ëÇÑÀÓ»óÅëÁõÇÐȸ
¿¬¶ôó : 02-958-8567  
À̸ÞÀÏ : kapainmed@hanmail.net      
±³À°Á¾·ù : ÀçÈ°ÀÇÇаú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Àü¹®ÀÇ »çÀüµî·Ï: 60,000¿øÀü°øÀÇ »çÀüµî·Ï: 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 09:30~10:00 Recent updates on diagnosis and treatment of RA and SpA: Guideline review  ¹æ¼Ò¿µ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 10:00~10:30 Radiologic assessment of RA and SpA  °­¿ì¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 10:30~11:00 Recent updates on pharmacologic treatment for RA and SpA  Á¤»óÀ±(Â÷ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 11:00~11:30 PMR physician¡¯s view: case-oriented clinical practice of RA and SpA  ±èµÎȯ(Áß¾ÓÀÇ´ë) 
Åä·Ð 09-25  11:30~11:40 Q&A  () 
±âŸ 09-25 ½Ç½Ã°£ 11:40~12:00 Á¦22Â÷ Á¤±âÃÑȸ  () 
½Ä»ç 09-25  12:00~13:00 Lunch  () 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 13:00~13:30 New concepts, phenotypes and critical aggravating factors of OA  ÀÌÀνÄ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 13:30~14:00 Recent updates and clinical experiences on pharmacologic treatment of OA  Àå¹Îö(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 14:00~14:30 Interventional and surgical treatment for osteoarthritis: update and review  ¿ÕÁØÈ£(¼º±Õ°üÀÇ´ë) 
Åä·Ð 09-25 ½Ç½Ã°£ 14:30~15:00 Coffee break  () 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 15:00~15:30 Treatment strategies for immunosuppressive/immunomodulatory agents  ÀÌÀº¿µ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 15:30~16:00 Exercise for inflammatory/degenerative arthropathy: how? How much?  ¹Î°æÈÆ(Â÷ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 16:00~16:30 Safety issues that should be considered in pharmacologic treatment:pregnancy, COVID-19 vaccination, other immunotherapy  ¼­Ã¢Èñ(¾ÆÁÖÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÀå³»½Ã°æÀ» À§ÇÑ ÀåÁ¤°áÁ¦°¡ ¾ó¸¶³ª ¹ßÀüÇßÀ»±î? : 2021-09-25
´ÙÀ½±Û 2021³â Á¦ 10Â÷ ´ëÇÑôÃßÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 75 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 39 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 45 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 33 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 21 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 21 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 29 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 23 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 14 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 26 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 31 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 30 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 38 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷